Royal Bank Of Canada reaffirmed their outperform rating on shares of Concordia Healthcare Corp (TSE:CXR) in a research note published on Monday. The brokerage currently has a C$18.00 price target on the stock.

A number of other equities analysts also recently issued reports on CXR. TD Securities cut their price target on Concordia Healthcare Corp from C$45.00 to C$37.00 and set a buy rating for the company in a research note on Tuesday, June 28th. Goldman Sachs Group Inc. set a C$34.00 price target on Concordia Healthcare Corp in a research note on Friday, July 22nd. Finally, CIBC downgraded Concordia Healthcare Corp from a sector perform rating to an underperform rating in a research note on Monday, August 15th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and an average price target of C$27.25.

Concordia Healthcare Corp (TSE:CXR) opened at 4.64 on Monday. The stock’s 50 day moving average price is $7.66 and its 200 day moving average price is $23.75. Concordia Healthcare Corp has a 52-week low of $4.52 and a 52-week high of $58.75. The firm’s market capitalization is $236.72 million.

Concordia Healthcare Corp Company Profile

Receive News & Stock Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related stocks with our FREE daily email newsletter.